ZTEK

+ Watchlist + Portfolio

Zentek Ltd.

Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.00
52-Week Range: $0.37 – $1.10
Market Cap: $62.30M
P/E (TTM): —
EPS (TTM): -0.07
Dividend Yield: —

Advanced Metrics

Price/Book: 3.42
PEG Ratio: —
Return on Equity: -53.24%
Return on Assets: -27.71%
Gross Margin: 0.00%
Operating Margin: -10104.33%
Profit Margin: 0.00%
Current Ratio: 4.65
Debt/Equity: 0.08
Total Debt: $1.93M
Free Cash Flow: $-4.48M
Revenue Growth: —
Earnings Growth: —
Enterprise Value: $45.49M

ZTEK Income statement, annual periods, in CAD
CAD	FY2023	FY2024	FY2025	FY2026
Revenue	$72.86K	$29.82K	$872.50K	$166.05K
Cost of Revenue	$853.34K	$331.08K	$644.61K	$1.84M
Gross Profit	-$780.48K	-$301.26K	$227.88K	-$1.67M
Research & Development	$1.65M	$1.78M	$465.65K	$1.65M
Selling, General & Admin	$10.99M	$8.95M	$8.01M	$6.27M
Operating Expenses	$14.73M	$12.01M	$9.83M	$8.26M
Operating Income	-$14.65M	-$11.98M	-$9.60M	-$9.93M
EBITDA	-$13.75M	-$11.08M	-$9.35M	-$8.98M
Pretax Income	-$14.41M	-$11.80M	-$10.04M	-$9.77M
Income Tax	$0.00	-$99.78K	$0.00	—
Net Income	-$14.41M	-$11.70M	-$10.04M	-$9.77M
Diluted EPS	-0.14	-0.12	-0.10	-0.09
Diluted Shares	99.44M	100.50M	102.98M	105.92M

ZTEK Balance Sheet statement, annual periods, in CAD
CAD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$10.36M	$3.52M	$121.48K	$1.30M
Receivables	$3.55M	$839.79K	$1.20M	$371.25K
Inventory	$2.85M	$1.42M	$887.51K	$417.55K
Current Assets	$17.95M	$6.25M	$4.37M	$2.28M
Total Assets	$33.29M	$22.59M	$18.40M	$15.09M
Current Liabilities	$2.42M	$1.82M	$3.49M	$3.53M
Long-Term Debt	—	$259.11K	—	$1.75M
Total Debt	$1.61M	$1.24M	$680.47K	$1.91M
Total Liabilities	$2.90M	$2.41M	$3.65M	$5.28M
Retained Earnings	-$66.20M	-$76.62M	-$83.85M	-$91.22M
Shareholders' Equity	$30.38M	$20.17M	$14.75M	$9.80M
Working Capital	$15.53M	$4.43M	$882.89K	-$1.26M
Net Debt	—	—	$225.27K	$448.58K

ZTEK Cash Flow statement, annual periods, in CAD
CAD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	-$12.96M	-$8.05M	-$6.28M	-$5.07M
Capital Expenditure	-$2.27M	-$591.96K	-$184.61K	-$701.86K
Free Cash Flow	-$15.23M	-$8.64M	-$6.47M	-$5.77M
Depreciation & Amortisation	$539.69K	$613.71K	$600.32K	$526.40K
Stock-Based Compensation	$3.20M	$1.79M	$1.53M	$1.26M
Investing Cash Flow	-$2.31M	$1.88M	$358.65K	$1.67M
Financing Cash Flow	-$1.05M	-$665.47K	$2.52M	$4.58M
Net Change in Cash	-$16.32M	-$6.84M	-$3.40M	$1.18M

ZTEK Income statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$813.60K	$57.80K	$6.20K	$65.28K	$36.77K	$0.00
Cost of Revenue	$267.50K	$30.60K	$3.23K	$90.19K	$1.71M	$0.00
Gross Profit	$546.09K	$27.20K	$2.98K	-$24.91K	-$1.68M	$0.00
Research & Development	$203.30K	$140.79K	$267.91K	$744.62K	$500.07K	$242.03K
Selling, General & Admin	$2.13M	$1.35M	$1.84M	$1.75M	$1.34M	$1.39M
Operating Expenses	$2.91M	$1.83M	$2.33M	$2.36M	$1.74M	$2.08M
Operating Income	-$2.10M	-$1.80M	-$2.32M	-$2.39M	-$3.42M	-$2.08M
EBITDA	-$1.88M	-$1.17M	-$2.19M	-$2.29M	-$3.33M	-$1.85M
Pretax Income	-$1.84M	-$1.36M	-$2.39M	-$2.49M	-$3.53M	-$2.04M
Income Tax	$0.00	—	—	—	—	—
Net Income	-$1.84M	-$1.36M	-$2.39M	-$2.49M	-$3.53M	-$2.04M
Diluted EPS	—	-0.01	-0.02	-0.02	—	-0.02
Diluted Shares	—	104.58M	104.72M	106.76M	—	115.40M

ZTEK Balance Sheet statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$121.48K	$2.89M	$1.33M	$1.80M	$1.30M	$16.60M
Receivables	$1.20M	$394.43K	$226.22K	$445.29K	$371.25K	$391.78K
Inventory	$887.51K	$892.32K	$888.98K	$838.43K	$417.55K	$393.49K
Current Assets	$4.37M	$4.53M	$2.75M	$3.32M	$2.28M	$17.60M
Total Assets	$18.40M	$18.48M	$16.87M	$17.38M	$15.09M	$30.86M
Current Liabilities	$3.49M	$2.80M	$3.48M	$3.33M	$3.53M	$3.79M
Long-Term Debt	—	$1.58M	$1.64M	$1.69M	$1.75M	$1.81M
Total Debt	$680.47K	$1.88M	$1.89M	$1.90M	$1.91M	$1.93M
Total Liabilities	$3.65M	$4.49M	$5.18M	$5.04M	$5.28M	$5.60M
Retained Earnings	-$83.85M	-$84.85M	-$87.23M	-$87.70M	-$91.22M	-$92.94M
Shareholders' Equity	$14.75M	$13.99M	$11.69M	$12.34M	$9.80M	$25.26M
Working Capital	$882.89K	$1.74M	-$730.86K	-$12.01K	-$1.26M	$13.81M
Net Debt	$225.27K	—	$303.17K	—	$448.58K	—

ZTEK Cash Flow statement, quarterly periods, in CAD
CAD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$1.28M	-$1.17M	-$1.21M	-$1.95M	-$734.92K	-$1.18M
Capital Expenditure	-$89.40K	-$53.24K	-$323.24K	-$151.00K	-$174.38K	-$583.02K
Free Cash Flow	-$1.37M	-$1.23M	-$1.53M	-$2.10M	-$909.31K	-$1.76M
Depreciation & Amortisation	$139.55K	$134.34K	$135.09K	$130.12K	$126.86K	$124.62K
Stock-Based Compensation	$279.68K	$121.56K	$69.30K	$530.58K	$534.69K	$401.70K
Investing Cash Flow	-$89.40K	$2.31M	-$323.24K	-$151.00K	-$171.36K	-$583.02K
Financing Cash Flow	$8.71K	$1.63M	-$22.13K	$2.57M	$407.85K	$17.06M
Share Repurchases	—	$0.00	$0.00	$0.00	—	—
Net Change in Cash	-$1.36M	$2.77M	-$1.55M	$466.57K	-$498.44K	$15.29M

Market Snapshot

About

Zentek is a nanotechnology company focused on developing antimicrobial solutions and materials. The company leverages graphene-based nanomaterials for applications in healthcare, consumer products, and industrial sectors. Zentek aims to address challenges in infection control and material performance through advanced nanomaterial technology.